Jane Street’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$150K Buy
20,800
+10,000
+93% +$87.1K ﹤0.01% 10303
2026
Q2
$113K Buy
+10,800
New +$80K ﹤0.01% 10531
2026
Q1
– Sell
-19,100
Closed -$138K – 12780
2025
Q4
$138K Buy
+19,100
New +$154K ﹤0.01% 9995

Other funds holding RNAC

Jane Street's RNAC Position: Q3 2026 in Review

Jane Street sold out of Cartesian Therapeutics (RNAC) in Q3 2026, closing a stake of 11,824 shares — an estimated $103K sold.

Jane Street first reported a position in RNAC in Q2 2019 and held it in 16 quarters. The position peaked at $478K in Q2 2020. 80 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.

  • Jane Street reported no remaining Cartesian Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jane Street sold 11,824 Cartesian Therapeutics shares in Q3 2026, an estimated $103K.
  • Jane Street first reported a position in Cartesian Therapeutics in Q2 2019 and held it in 16 quarters.
  • Jane Street's Cartesian Therapeutics position peaked at $478K in Q2 2020.
  • 80 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.